If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCharacter Regulatory News (CCT)

Share Price Information for Character (CCT)

Share Price is delayed by 15 minutes
Get Live Data
290.00    0.00 (0.00%)
Bid:
280.00
Ask:
300.00
Spread: 20.00 (7.143%)
Market Cap: £50.47m
CCT Live PriceLast checked at - London Stock Exchange

Intraday Character Share Chart

Trading Update

11 Apr 2025 07:00

RNS Number : 6015E
Character Group PLC (The)
11 April 2025
 

 

 

Friday, 11 April 2025

 

 

The Character Group plc

("Character", the "Company" or the "Group")

Trading update

 

The recent unilateral imposition by the USA of trade tariffs on imports, particularly from China, and the escalating retaliatory measures being adopted have greatly impacted global economic stability in a very short space of time. 

 

The Board's visibility for forecasting sales to USA (which were c.20% of Group turnover in the last financial year) and its ability to assess the financial implications for the Group have been considerably obscured by these events. Consequently, the effect of the imposition of the trade tariffs will be felt in the second half by the Group and, as a result, the Company is withdrawing the market guidance for the year ending 31 August 2025. Despite this, the Board remains confident that the Group will be profitable for the current financial year as a whole.

 

The review of the Company's H1 results, which are due to be published in mid-May, is not yet complete, however, all indications at this time are that, in accordance with market expectations, the trading results to February 2025 will be in line with the first-half performance in the prior year (HY 2024 profit before tax and highlighted items: £2.1m).

 

The Company continues to have a strong balance sheet with healthy cash balances and the Board is confident that it can ride out this storm. As we gain a clearer picture of the global economic landscape emerging, we will update shareholders further.

 

 

 

 

 

Enquiries to:

The Character Group plc

Jon Diver, Joint Managing Director

Kiran Shah, Joint Managing Director

Hamun Shah, Group Finance Director

Office: +44 (0) 208 329 3377

 

Panmure Liberum (Nominated Adviser and Joint Broker)

Atholl Tweedie, Investment Banking

Rupert Dearden, Corporate Broking

Tel: +44 (0) 20 7886 2500

Allenby Capital Limited (Joint Broker)

Nick Athanas, Corporate Finance

Amrit Nahal / Tony Quirke, Sales & Corporate Broking

Tel: +44 (0) 20 3328 5656

 

TooleyStreet Communications Limited (Investor and media relations)

Fiona Tooley

Tel: +44 (0) 7785 703523

Email: fiona@tooleystreet.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSFFEFSEISESL
Date   Source Headline
17th Dec 20187:00 amRNSTransaction in own shares and TVR
14th Dec 20185:42 pmRNSHolding(s) in Company
14th Dec 20187:00 amRNSTransaction in Own Shares
12th Dec 20187:00 amRNSStatement re Share buy-backs
29th Nov 20187:00 amRNSPreliminary results - year ended 31 August 2018
23rd Nov 20185:10 pmRNSHolding(s) in Company
15th Nov 20189:39 amRNSCharacter list in Dream Toys Christmas dream dozen
18th Oct 20187:17 amRNSCharacter acquires 55% in Nordic based toy company
14th Sep 20187:00 amRNSTrading Update
13th Sep 20185:35 pmRNSDirector/PDMR Shareholding
4th Sep 201812:27 pmRNSTotal Voting Rights
30th Aug 20182:43 pmRNSHolding(s) in Company
7th Aug 20185:28 pmRNSTotal Voting Rights
3rd Jul 20185:39 pmRNSTotal Voting Rights
6th Jun 20183:17 pmRNSDirector/PDMR Shareholding
4th Jun 20186:00 pmRNSBlock listing Interim Review
4th Jun 20187:00 amRNSTotal Voting Rights
8th May 20187:00 amRNSHolding(s) in Company
25th Apr 20187:00 amRNSHalf-yearly Financial Report - period to Feb 2018
3rd Apr 20182:50 pmRNSTotal Voting Rights
1st Mar 20184:29 pmRNSTotal Voting Rights
2nd Feb 201811:21 amRNSTotal Voting Rights
25th Jan 20187:00 amRNSTransaction in Own Shares
24th Jan 20181:35 pmRNSCharacter scoops two Toy Awards
19th Jan 201812:21 pmRNSANNUAL GENERAL MEETING
19th Jan 20187:55 amRNSTrading update
5th Jan 20185:48 pmRNSTransaction in Own Shares & Revised TVR
5th Jan 20185:45 pmRNSDirector/PDMR Shareholding
4th Jan 20186:25 pmRNSTotal Voting Rights
21st Dec 20172:08 pmRNSAnnual Financial Report
14th Dec 20177:00 amRNSShare Buyback and Total Voting Rights
5th Dec 20177:00 amRNSPreliminary Results - year ended 31 August 2017
8th Nov 201711:33 amRNS"2 in the Dream Toys Dozen for Character"
1st Nov 20172:23 pmRNSTotal Voting Rights
26th Oct 20176:16 pmRNSTransaction in Own Shares
16th Oct 201710:34 amRNSDirector/PDMR Shareholding
11th Oct 20175:34 pmRNSTransaction in Own Shares
11th Oct 20174:40 pmRNSSecond Price Monitoring Extn
11th Oct 20174:35 pmRNSPrice Monitoring Extension
11th Oct 201712:56 pmRNSTransaction in Own Shares
11th Oct 20178:00 amRNSTrading Update
4th Oct 20175:45 pmRNSTotal Voting Rights
19th Sep 20174:45 pmRNSTrading update
15th Sep 20177:00 amRNSBoard Change
6th Sep 20177:00 amRNSCharacter Group adds Pokémon to its portfolio
31st Aug 20174:35 pmRNSTotal Voting Rights
15th Aug 20177:58 amRNSTransaction in Own Shares
14th Jul 20177:00 amRNSCharacter renews licence for Teletubbies
3rd Jul 20175:55 pmRNSBlock listing Interim Review
12th May 20171:15 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.